Synopsis

Source of validity: Scientific
Rating (out of 5): 2

AHCC (Active Hexose Correlated Compound) is a proprietary extract of cultured lentinula edodes (shiitake) mycelia. Its use in supporting patients with Acquired Immune Deficiency Syndrome (AIDS) is grounded in limited scientific investigation rather than longstanding traditional use. Several in vitro and animal studies suggest that AHCC may modulate immune responses, notably by increasing natural killer (NK) cell activity, cytokine production, and enhancing macrophage and dendritic cell function. Some small clinical studies and case reports have explored its use in HIV/AIDS, with findings suggesting potential improvements in certain immune parameters, such as elevated CD4+ T cell counts or improved subjective well-being. However, these studies are typically limited by small sample sizes, lack of rigorous controls, and short duration. Systematic reviews and larger randomized controlled trials specific to AHCC in HIV/AIDS populations are lacking, and no major clinical guidelines recommend AHCC for this indication. Thus, while there is some preliminary scientific interest and evidence pointing to possible immunomodulatory benefits, the overall level of scientific validation is low, and its efficacy and safety for treating or supporting AIDS remain unproven.

More about AHCC
More about Acquired Immune Deficiency Syndrome

Other ingredients used for Acquired Immune Deficiency Syndrome

Other health conditions supported by AHCC

Products containing AHCC